Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
10 MBq/kg Betalutin
DRUG
2 trials
Sponsors
Nordic Nanovector
Conditions
Follicular Lymphoma
Non Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Relapsed Follicular Lymphoma
Phase 1
A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma
Completed
NCT01796171
Nordic Nanovector
Follicular Lymphoma, Non-Hodgkin Lymphoma
Start: 2012-12-31
End: 2022-10-27
Updated: 2024-06-21
Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL
Completed
NCT03806179
Nordic Nanovector
Follicular Lymphoma, Non Hodgkin Lymphoma, Relapsed Follicular Lymphoma
Start: 2018-10-04
End: 2022-08-08
Updated: 2023-12-22
Related Papers
System-Level Barriers to Uptake of Existing and Novel Radioimmunotherapy for People with Lymphoma
Blood
2021-11-05
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of <sup>177</sup>Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma.
2020-11-16
7 citations
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma
Blood Advances
2020-09-02
44 citations